Clinical trial

Probiotics and Allergic Diseases

NCT01635738

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhaseNA

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2015-09-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atopic Dermatitisverified · MONDO: atopic eczema

Asthmaverified · MONDO: asthma

Interventions

LP GMNL-133 capsuleBIOLOGICAL

LF GM-090 capsuleBIOLOGICAL

LP GMNL-133 +LF GM-090 capsuleBIOLOGICAL

PlaceboBIOLOGICAL

Sponsors & collaborators

GenMont Biotech Incorporationlead sponsor

National Science and Technology Council, Taiwancollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01635738 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.